Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.90
Bid: 4.80
Ask: 5.00
Change: 0.05 (1.03%)
Spread: 0.20 (4.167%)
Open: 4.85
High: 4.90
Low: 4.85
Prev. Close: 4.85
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licence Agreement with SUMIAGRO

1 Dec 2014 07:00

RNS Number : 3789Y
Eden Research plc
01 December 2014
 



Eden Research Plc

("Eden" or "Company")

 

Exclusive Licence Agreement with SUMIAGRO France SAS for grape protection products

 

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has signed an exclusive Licence Agreement with Sumi Agro France SAS ("Sumi Agro") to sell 3AEY, an Eden-developed plant protection product in France. In addition, Sumi Agro will have the right to trial, register, develop and sell certain other plant protection products for use in France using Eden's natural encapsulation technology, GO-E Inside™.

 

The Licence Agreement, which lasts for 20 years, covers the use of 3AEY in a number of agricultural applications and the initial targeted use will be on grapes for control of Botrytis, a fungus that affects many plants and is a major concern across Europe.

 

This follows the news announced on 21 November 2014 that Eden signed an exclusive Licence Agreement with Sipcam Italia Spa and Sipcam Iberia to sell 3AEY in Italy and Spain, respectively. 

 

Under the terms of the agreement, Eden will receive an upfront payment followed by a number of milestone payments relating to the approval of the product by the EU, which is expected in spring 2015, and sales targets. Eden will also receive ongoing royalty payments based on product sales. 

 

Sean Smith, Chief Executive Officer of Eden, said: "France is a well-known grape growing country where the market for Botryticides is, historically, the largest in the world. Ensuring that we have the right partner which is able to fully exploit the opportunities for effective products such as 3AEY in this market is, therefore, critical. We strongly believe that SUMIAGRO France is that partner and expect that Eden will benefit greatly from the weight that their name and expertise carries in France.

 

Beyond this agreement and 3AEY, we look forward to developing other product opportunities with Sumi Agro France as well as with affiliated Sumitomo Corporation companies. "

 

Antoine Meyer, President of Sumi Agro, said: "We fully recognize that, with 3AEY, Eden's technology is clearly an innovative BioControl answer to vineyard growers looking to satisfy their workers' concerns and consumers' demand: 3AEY botryticide provides distributors and growers with a new tool adapted to modern and increasingly sustainable farming.

 

This agreement expresses our Sumi Agro commitment to invest in modern crop protection solutions based on conventional as well as BioControl tools."

 

Eden Research plc

www.edenresearch.com

Sean Smith, Chief Executive Officer

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited

Tel: 0117 945 3471

John Wakefield / Ed Allsopp

Walbrook PR Ltd

Tel: 020 7933 8780 or eden@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

Notes:

 

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

 

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic hydrophobic compounds. The technology uses yeast cells that are a by-product of numerous commercial production processes to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

 

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

 

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

 

The Company has a number of patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property and seeking regulatory approval for products that rely upon the Company's technologies. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, gaining regulatory approvals, identifying suitable industrial partners, and entering into licence agreements.

 

In May of 2013, the three actives that comprise Eden's first commercial product, 3AEY, were approved as new ingredients for use in plant protection products. This represents a major milestone in the commercialisation of Eden's technology and is a significant accomplishment for any company. To illustrate this point, one should note that in all of 2013, Eden's approvals represented 3 of only 10 new active ingredients approved by the EC.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

For more information about Eden, please visit www.edenresearch.com

 

 

 

Sumi Agro France is a European affiliated company of the Japanese SUMITOMO CORPORATION group, one of the largest trading house in the World. In 2012, Sumi Agro and Sipcam signed an alliance, creating a common platform for the development, marketing and distribution of products for Agriculture, covering all European markets.

 

Thanks to its closed relationship with numerous corporations, not only in Asia, but everywhere in the World, Sumi Agro has a continuous access to new active ingredients and technologies.

 

Sumi Agro built solutions for an efficient crop protection, economically relevant and consistent with a Sustainable Agriculture, respecting the Environment and able to supply quality food for all.

 

Sumi Agro is a member of ECPA / UIPP and IBMA associations.

For more information about SUMI AGRO, please visit www.sumiagro.fr - www.sumiagro.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPGGMWGUPCGQR
Date   Source Headline
24th Sep 20187:00 amRNSHalf-year Report
13th Jul 201810:23 amRNSDirector/PDMR Shareholding
21st Jun 20184:44 pmRNSResult of AGM
21st Jun 20187:00 amRNSAGM Statement
19th Jun 20187:00 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSRegulatory Progress Update
30th May 20182:30 pmRNSPosting of Annual Report & Notice of AGM
10th May 20185:04 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSExercise of Options
20th Mar 20187:00 amRNSPreliminary results
11th Jan 20187:00 amRNSYear-end Trading Statement
12th Dec 20177:00 amRNSRegulatory Progress Update
29th Sep 201711:15 amRNSHalf-year Report - Replacement
29th Sep 20177:30 amRNSAdoption of New LTIP and Grant of Awards
29th Sep 20177:01 amRNSBoard Changes
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:00 amRNSApproval of MevaloneT in Portugal
1st Sep 20177:00 amRNSNotice of Results
30th Jun 20175:14 pmRNSHolding(s) in Company
30th Jun 201712:29 pmRNSResult of AGM
30th Jun 20177:43 amRNSAGM Statement
30th Jun 20177:39 amRNSCompletion of Placing & Subscription
30th Jun 20177:00 amRNSSipcam agreements, investment and proposed placing
29th Jun 20179:43 amRNSNew terms agreed with UMMS
5th Jun 20173:14 pmRNSPosting of Annual Report & Notice of AGM
22nd May 20177:00 amRNSFinal Results
11th May 20179:00 amRNSEden Research on BBC Radio 4's You & Yours
29th Mar 20177:00 amRNSExtension of patent protection in Greece
8th Mar 20172:40 pmRNSVoting Rights, Warrants and Options Outstanding
23rd Jan 20172:00 pmRNSPrice Monitoring Extension
23rd Jan 20177:00 amRNSFungicide product approved for sale in France
21st Dec 20167:01 amRNSTrading update
21st Dec 20167:00 amRNSEastman commercialisation agreement for nematicide
27th Sep 20167:00 amRNSHalf-year Report
28th Jun 201612:28 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
15th Jun 20167:00 amRNSLabel extensions for 3AEY in Spain and Greece
7th Jun 20167:00 amRNSPosting of Annual Report & Notice of AGM
26th May 20163:36 pmRNSDirector/PDMR Shareholding
24th May 20167:00 amRNSFinal Results
11th Apr 20169:31 amRNSHolding(s) in Company
30th Mar 20167:00 amRNSPlacing to raise £2.6m
22nd Feb 20167:00 amRNSApproval of 3AEY in Spain
11th Feb 20167:00 amRNSApproval of 3AEY in Italy
10th Feb 20167:00 amRNSFirst shipment of MevaloneT (3AEY) to Greece
21st Jan 20167:00 amRNSExercise of options
14th Jan 20167:00 amRNSFurther progress with EU product approvals
16th Nov 20157:00 amRNSKenya approval & first commercial-scale order
26th Oct 20157:00 amRNSAppointment of Nominated Adviser and Broker
24th Sep 20157:00 amRNSCollaboration and Licence Agreement Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.